Evidence map›Paper›PMID 35980542›Full record

ReviewDrug delivery and translational research2023

The exosome: a review of current therapeutic roles and capabilities in human reproduction.

Marko Dimik, Pevindu Abeysinghe, Jayden Logan, Murray Mitchell

Abstract readReview
In one paragraph

Review in Drug delivery and translational research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Review
  14. Review
  15. Review
  16. Review
  17. Role of Seminal Exosomes in Reproduction.Journal of cellular physiology · 2025
    Review
  18. Review
  19. Review
  20. The effect of plasma exosomal microRNA- 148a- 3p on the CD4Archives of dermatological research · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Marko DimikCentre for Children's Health Research, School of Biomedical Sciences, Faculty of Health, Queensland University of Technology, Level 8, 62 Graham Street, South Brisbane, QLD, 4101, Australia. marko.dimik@hdr.qut.edu.au.ORCID 0000-0001-8046-8794
Pevindu AbeysingheCentre for Children's Health Research, School of Biomedical Sciences, Faculty of Health, Queensland University of Technology, Level 8, 62 Graham Street, South Brisbane, QLD, 4101, Australia.ORCID 0000-0001-9354-352X
Jayden LoganCentre for Children's Health Research, School of Biomedical Sciences, Faculty of Health, Queensland University of Technology, Level 8, 62 Graham Street, South Brisbane, QLD, 4101, Australia.
Murray MitchellCentre for Children's Health Research, Leader - Child and Reproductive Health Group, Centre for Immunology and Infection Control, School of Biomedical Sciences, Faculty of Health, Queensland University of Technology, Brisbane, Australia.ORCID 0000-0002-6167-7176

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Exosomes are nano-vesicles (30-150 nm) which may be useful as therapeutic delivery vehicles and as diagnostic biomarkers. Exosomes are produced naturally within the human body and therefore are not prone to immunogenicity effects which would otherwise destroy unelicited foreign bodies. Clinically, they have been regarded as ideal candidates for applications relating to biomarker developments for the early detection of different diseases. Furthermore, exosomes may be of interest as potential drug delivery vehicles, which may improve factors such as bioavailability of loaded molecular cargo, side effect profiles, off-target effects, and pharmacokinetics of drug molecules. In this review, the therapeutic potential of exosomes and their use as clinical biomarkers for early diagnostics will be explored, alongside exosomes as therapeutic delivery vehicles. This review will evaluate techniques for cargo loading, and the capacity of loaded exosomes to improve various reproductive disease states. It becomes important, therefore, to consider factors such as loading efficiency, loading methods, cell viability, exosomal sources, exosome isolation, and the potential therapeutic benefits of exosomes. Issues related to targeted drug delivery will also be discussed. Finally, the variety of therapeutic cargo and the application of appropriate loading methods is explored, in the context of establishing clinical utility. Exosomes have more recently been widely accpeted as potential tools for disease diagnostics and the targeted delivery of certain therapeutic molecules-and in due time exosomes will be utilised more commonly within the clinical setting. Specifically, exosomal biomarkers can be identified and related to various detrimental conditions which occur during pregnancy. Considering, this review will explore the potential future of exosomes as both diagnostic tools and therapeutic delivery vehicles to treat related conditions, including the challenges which exist towards incorporating exosomes within the clinical environment to benefit patients.

Indexed as

ExosomesBiomarkersDrug Delivery SystemsExcipientsHumansReproductionBiomarkersExcipientsDrug deliveryExosomal biomarkersExosome cargo loadingNanomedicineNanotherapeutics

Identifiers

PMID35980542
PMCPMC9794547

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.